Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines

Infection and Immunity

Volumn 64, Issue 4, 1996, Pages 1173-1180

  Ramegowda, Belakere ^a   Tesh, Vernon L ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBOTRIAOSYLCERAMIDE; INTERLEUKIN 1BETA; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA; VEROTOXIN;

ACUTE KIDNEY FAILURE; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; IMMUNOREGULATION; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; SHIGELLA DYSENTERIAE; TOXIN ANALYSIS;

EID: 0030002051     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.4.1173-1180.1996     Document Type: Article

References (39)

1. Aeheson, D. W. K., A. Donohue-Rolfe, and G. T. Keusch. 1991. The family of Shiga and Shiga-like toxins, p. 415-433. In J. E. Alouf and J H. Freer (ed.), Sourcebook of bacterial protein toxins Academic Press, London.
2. Auwerx, J. 1991. The human leukemia cell line THP-1: a multifacetted model for the study of monocyte-macrophage differentiation Experientia 47:22-31
3. Barrett, T. J., M. E. Potter, and N. A. Strockbine. 1990. Evidence for participation of the macrophage in Shiga-like toxin II-induced lethality in mice. Microb. Pathog. 9:95-103.
4. Barrett, T. J., M. E. Potter, and I. K. Wachsmuth. 1989. Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice. Infect. Immun. 57:3434-3437.
5. Cohen, A., V. Madrid-Marina, Z. Estrov, M. H. Freedman, C. A. Lingwood, and H.-M. Dosch. 1990. Expression of glycolipid receptors to Shiga-like toxin on human B-lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease. Int. Immunol. 2:1-8.
6. Eiklid, K., and S. Olsnes. 1980. Interaction of Slugella shigae cytotoxin with receptor on sensitive and insensitive cells J. Recept. Res. 1:199-212.
7. Fenton, M. J., M. W. Vermeulen, B. D. Clark, A. C. Webb, and P. E. Auron. 1988. Human proIL-1 beta gene expression in monocytic cells is regulated by two distinct pathways. J. Immunol. 140:2267-2273.
8. Griffin, P. M., B. P. Bell, P. R. Cieslak, J. Tuttle, T. J. Barrett, M. P. Doyle, A. M. McNamara, A. M. Shefer, and J. G. Wells. 1994. Large outbreak of Escherichia coli O157:H7 infections in the western United States: the big picture, p. 7-12. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science, Amsterdam
9. Gyles, C. L. 1994. VT toxemia in animal models, p. 233-240 In M. A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science, Amsterdam.
10. Harris, P., and P. Ralph. 1985. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J. Leukocyte Biol. 37:407-422.
11. Jacewicz, M., H. A. Feldman, A. Donohue-Rolfe, K. A. Balasubramanian, and G. T. Keusch. 1989. Pathogenesis of Shigella diarrhea XIV. Analysis of Shiga toxin receptors on cloned HeLa cells. J. Infect. Dis. 159:881-889.
12. 3, is required but not sufficient to confer sensitivity to Shiga toxin. J. Infect. Dis. 169:538-546.
13. Jacewicz, M. S., D. W. K. Acheson, M. Mobassaleh, A. Donohue-Rolfe, K. A. Balasubramanian, and G. T. Keusch. 1995. Maturational regulation of globotriaosylceramide. the Shiga-like toxin I receptor, in cultured human gut epithelial cells. J. Clin. Invest. 96:1328-1335.
14. Jackson, M. P., R. J. Neill, A, D. O'Brien, R. K. Holmes, and J. W. Newland. 1987. Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol. Lett 44:109-114
15. Kiarash, A., B. Boyd, and C. A. Lingwood. 1994. Glycosphingolipid receptor function is modified by fatty acid content: verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosylceramide fatty acid homologues,. J. Biol. Chem. 269:11138-11146.
16. Kniep, B., D. A. Monner, U. Schwulera, and P. F. Muhlradt. 1985. Glycosphingolipids of the globo-series are associated with the monocytic lineage of human myeloid cells. Eur. J. Biochem 149:187-191.
17. Koeffler, H. P. 1983. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 62:709-721.
18. Louise, C. B., S. A. Kaye, B. Boyd, C. A. Lingwood, and T. G. Obrig. 1995. Shiga toxin-associated hemolytic-uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin Infect Immun 63:2766-2769
19. Louise, C. B., and T. G. Obrig. 1991. Shiga toxin-associated hemolyticuremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1β, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect. Immun. 59:4173-4179.
20. Maloney, M., and C. A. Lingwood. 1993 Interaction of verotoxins with glycosphingolipids. Trends Glycosci. Glycotechnol. 5:23-31.
21. Minta, J. O., and L. Pambrum. 1985. In vitro induction of cytologic and functional differentiation of the immature human monocyte-like cell line U-937 with phorbol myristate acetate. Am. J. Pathol. 119:111-126.
22. O'Brien, A. D., V. L. Tesh, A. Donohue-Rolfe, M. P. Jackson, S. Olsnes, K. Sandvig, A. A. Lindherg, and G. T. Keusch. 1992. Shiga toxin: biochemistry, genetics, mode of action and role in pathogenesis. Curr. Top. Microbiol Immunol. 180:67-94.
23. Obrig, T. G., P. J. DelVecchio, J. E. Brown, T. P, Moran, B. M. Rowland, T. K. Judge, and S. W. Rothman. 1988. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect. Immun. 56:2373-2378.
24. Obrig, T. G., C. B. Louise, C. A. Lingwood, B. Boyd, L. Barley-Maloney, and T. O. Daniel. 1993. Endothelial heterogeneity in Shiga toxin receptors and responses. J. Biol. Chem. 268:15484-15488.
25. Raqib, R., A. A. Lindberg, B. Wretlind, P. K. Bardhan, U. Andersson, and J. Andersson. 1995. Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect. Immun. 63:289-296.
26. Richardson, S. E., M. A. Karmali, L. E. Becker, and C. R, Smith. 1988. The histopathology of the hemolytic uremic syndrome (HUS) associated with verocytotoxin-producing Escherichia coli (VTEC) infections Hum. Pathol 19:1102-1108.
27. Sandvig, K., M. Ryd, Ø. Garred, E. Schweda, P. K. Holm, and B. van Deurs. 1994. Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga-B-fragment is regulated by butyric acid and CAMP. J. Cell Biol. 126:53-64.
28. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314.
29. Strockhine, N. A., L. R. M. Marques, R. K. Holmes, and A. D. O'Brien. 1985 Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli. Infect. Immun. 50:695-700.
30. Strockbine, N. A., L. R. M. Marques, J. W. Newland, H. W. Smith, R. K. Holmes, and A. D. O'Brien. 1986. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect. Immun 53:135-140.
31. Sundström, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int. J. Cancer 17:565-577.
32. Tesh, V. L., B. Ramegnwda, and J. E. Samuel. 1994 Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect. Immun. 62:5085-5094.
33. Tesh, V. L., J. E. Samuel, L. P. Perera, J. B. Sharefkin, and A, D. O'Brien. 1991. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J. Infect. Dis. 164:344-352.
34. Tsuchiya, S., Y. Kobayashi, Y. Goto, H. Okamura, S. Nakae, T. Konno, and K. Tada. 1982. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42:1530-1534.
35. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26:171-176.
36. Unanue, E. R., and P. M. Allen. 1987. The basis for the immunoregulatory role of macrophages and other accessory cells. Science 236:551-557.
37. Van der Kar, N. C. A. J., L. A. H. Monnens, M. A. Karmali, and V. W. M. van Hinsbergh. 1992. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80:2755-2764.
38. Waddell, T., A. Cohen, and C. A. Lingwood. 1990. Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriaosylceramide. Proc Natl Acad. Sci. USA 87:7898-7901.
39. Ways, D., R. Riddle, M. Ways, and P. Cook. 1991. Effect of phorbol esters on cytosolic protein kinase C content and activity in the human monoblastoid U-937 cell. J. Biol. Chem. 262:1258-1264.